Fox AH, Nakagawa S, Hirose T, Bond CS. Paraspeckles: where long noncoding RNA meets phase separation. Trends Biochem Sci. 2018;43:124–35.

Article  CAS  PubMed  Google Scholar 

Naganuma T, Nakagawa S, Tanigawa A, Sasaki YF, Goshima N, Hirose T. Alternative 3'-end processing of long noncoding RNA initiates construction of nuclear paraspeckles. EMBO J. 2012;31:4020–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wilusz JE, JnBaptiste CK, Lu LY, Kuhn CD, Joshua-Tor L, Sharp PA. A triple helix stabilizes the 3' ends of long noncoding RNAs that lack poly(A) tails. Genes Dev. 2012;26:2392–407.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Hu SB, Wang MR, Yao RW, Wu D, Yang L, et al. Genome-wide screening of NEAT1 regulators reveals cross-regulation between paraspeckles and mitochondria. Nat Cell Biol. 2018;20:1145–58.

Article  CAS  PubMed  Google Scholar 

Wang Z, Li K, Huang W. Long non-coding RNA NEAT1-centric gene regulation. Cell Mol Life Sci. 2020;77:3769–79.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Y, Chen LL. Organization and function of paraspeckles. Essays Biochem. 2020;64:875–82.

Article  CAS  PubMed  Google Scholar 

Smith NE, Spencer-Merris P, Fox AH, Petersen J, Michael MZ. The long and the short of it: NEAT1 and cancer cell metabolism. Cancers. 2022;14:4388.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hirose T, Virnicchi G, Tanigawa A, Naganuma T, Li R, Kimura H, et al. NEAT1 long noncoding RNA regulates transcription via protein sequestration within subnuclear bodies. Mol Biol Cell. 2014;25:169–83.

Article  PubMed  PubMed Central  Google Scholar 

Kawaguchi T, Tanigawa A, Naganuma T, Ohkawa Y, Souquere S, Pierron G, et al. SWI/SNF chromatin-remodeling complexes function in noncoding RNA-dependent assembly of nuclear bodies. Proc Natl Acad Sci USA. 2015;112:4304–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McCluggage F, Fox AH. Paraspeckle nuclear condensates: global sensors of cell stress? Bioessays. 2021;43:e2000245.

Article  PubMed  Google Scholar 

Laurenzi T, Palazzolo L, Taiana E, Saporiti S, Ben Mariem O, Guerrini U, et al. Molecular modelling of NONO and SFPQ dimerization process and RNA recognition mechanism. Int J Mol Sci. 2022;23:7626.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yamazaki T, Souquere S, Chujo T, Kobelke S, Chong YS, Fox AH, et al. Functional domains of NEAT1 architectural lncRNA Induce paraspeckle assembly through phase separation. Mol Cell. 2018;70:1038–53.e1037.

Article  CAS  PubMed  Google Scholar 

Kufe D. Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer. 2009;9:874–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kufe D. MUC1-C in chronic inflammation and carcinogenesis; emergence as a target for cancer treatment. Carcinogenesis. 2020;41:1173–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kufe D. Emergence of MUC1 in mammals for adaptation of barrier epithelia. Cancers. 2022;14:4805.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alam M, Bouillez A, Tagde A, Ahmad R, Rajabi H, Maeda T, et al. MUC1-C represses the Crumbs complex polarity factor CRB3 and downregulates the Hippo pathway. Mol Cancer Res. 2016;14:1266–76.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rajabi H, Alam M, Takahashi H, Kharbanda A, Guha M, Ahmad R, et al. MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial-mesenchymal transition. Oncogene. 2014;33:1680–9.

Article  CAS  PubMed  Google Scholar 

Hata T, Rajabi H, Yamamoto M, Jin C, Ahmad R, Zhang Y, et al. Targeting MUC1-C inhibits TWIST1 signaling in triple-negative breast cancer. Mol Cancer Ther. 2019;18:1744–54.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hiraki M, Maeda T, Bouillez A, Alam M, Tagde A, Hinohara K, et al. MUC1-C activates BMI1 in human cancer cells. Oncogene. 2017;36:2791–801.

Article  CAS  PubMed  Google Scholar 

Rajabi H, Hiraki M, Tagde A, Alam M, Bouillez A, Christensen CL, et al. MUC1-C activates EZH2 expression and function in human cancer cells. Sci Rep. 2017;7:7481.

Article  PubMed  PubMed Central  Google Scholar 

Rajabi H, Tagde A, Alam M, Bouillez A, Pitroda S, Suzuki Y, et al. DNA methylation by DNMT1 and DNMT3b methyltransferases is driven by the MUC1-C oncoprotein in human carcinoma cells. Oncogene. 2016;35:6439–45.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rajabi H, Hiraki M, Kufe D. MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells. Oncogene. 2018;37:2079–88.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhattacharya A, Fushimi A, Wang K, Yamashita N, Morimoto Y, Ishikawa S, et al. MUC1-C intersects chronic inflammation with epigenetic reprogramming by regulating the SET1A compass complex in cancer progression. Comms Biol. 2023;6:1030.

Article  CAS  Google Scholar 

Hata T, Rajabi H, Takahashi H, Yasumizu Y, Li W, Jin C, et al. MUC1-C activates the NuRD complex to drive dedifferentiation of triple-negative breast cancer cells. Cancer Res. 2019;79:5711–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hagiwara M, Yasumizu Y, Yamashita N, Rajabi H, Fushimi A, Long MD, et al. MUC1-C activates the BAF (mSWI/SNF) complex in prostate cancer stem cells. Cancer Res. 2021;81:1111–22.

Article  CAS  PubMed  Google Scholar 

Hagiwara M, Fushimi A, Yamashita N, Battacharya A, Rajabi H, Long M, et al. MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cells. Oncogene. 2021;40:4930–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bhattacharya A, Fushimi A, Yamashita N, Hagiwara M, Morimoto Y, Rajabi H, et al. MUC1-C dictates JUN and BAF-mediated chromatin remodeling at enhancer signatures in cancer stem cells. Mol Cancer Res. 2022;20:556–67.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yasumizu Y, Rajabi H, Jin C, Hata T, Pitroda S, Long MD, et al. MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer. Nat Commun. 2020;11:338.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li W, Zhang N, Jin C, Long MD, Rajabi H, Yasumizu Y, et al. MUC1-C drives stemness in progression of colitis to colorectal cancer. JCI Insight. 2020;5:137112.

Article  PubMed  Google Scholar 

Luan Z, Morimoto Y, Fushimi A, Yamashita N, Suo W, Bhattacharya A, et al. MUC1-C dictates neuroendocrine lineage specification in pancreatic ductal adenocarcinomas. Carcinogenesis. 2021;43:67–76.

Article  PubMed Central  Google Scholar 

Fushimi A, Morimoto Y, Ishikawa S, Yamashita N, Bhattacharya A, Daimon T, et al. Dependence on the MUC1-C oncoprotein in classic, variant and non-neuroendocrine small cell lung cancer. Mol Cancer Res. 2022;20:1379–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morimoto Y, Fushimi A, Yamashita N, Hagiwara M, Bhattacharya A, Cheng J, et al. Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment. Oncogene. 2022;41:3511–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yamashita N, Kufe D. Addiction of cancer stem cells to MUC1-C in triple-negative breast cancer progression. Int J Mol Sci. 2022;23:8219.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yamamoto M, Jin C, Hata T, Yasumizu Y, Zhang Y, Hong D, et al. MUC1-C integrates chromatin remodeling and PARP1 activity in the DNA damage response of triple-negative breast cancer cells. Cancer Res. 2019;79:2031–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shigeta K, Hasegawa M, Kikuchi E, Yasumizu Y, Kosaka T, Mizuno R, et al. Role of the MUC1-C oncoprotein in the acquisit